CHD4 and incontinentia pigmenti: Thus, it could be hypothesized that certain autoantibodies, such as Mi-2β, are continuously produced in idiopathic IP and do not diminish after treatment with immunosuppressive therapy, whereas antibodies in active CTD-ILD would be more likely the result of short-lived autoreactive plasma cells which are sensitive for immunosuppressants.